<DOC>
	<DOC>NCT00338273</DOC>
	<brief_summary>The purpose of this study is to evaluate flexible doses (5-30 mg) of aripiprazole in patients with bipolar depression.</brief_summary>
	<brief_title>A Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive Episode</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder, Major</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>Outpatients Must sign informed consent prior to protocolrelated procedures Women who are pregnant, trying to become pregnant, or nursing Significant risk of committing suicide Any serious unstable medical conditions</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Bipolar I disorder with major depressive episode</keyword>
</DOC>